Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer

Radiotherapy and Oncology

Volumn 99, Issue 1, 2011, Pages 12-17

  Nath, Sameer K ^a   Sandhu, Ajay P ^a   Kim, Daniel ^a   Bharne, Anjali ^a   Nobiensky, Polly D ^a   Lawson, Joshua D ^a   Fuster, Mark ^a,b   Bazhenova, Lyudmila ^a   Song, William Y ^a   Mundt, Arno J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Distant failures; Image guided radiation therapy (IGRT); Nodal failures; Non small cell lung cancer (NSCLC); Stereotactic body radiation therapy (SBRT)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER INCIDENCE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; STEREOTACTIC BODY RADIATION THERAPY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOGRAPHY, INTERVENTIONAL; RADIOSURGERY; RADIOTHERAPY DOSAGE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 79954609193     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.02.006     Document Type: Article

References (34)

1. American Cancer Society. Cancer Facts & Figures 2007: Atlanta: American Cancer Society. 2007.
2. W.R. Smythe Treatment of stage I non-small cell lung carcinoma Chest 123 2003 181S 187S (Pubitemid 36135716)
3. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group Ann Thorac Surg 60 1995 615 622 discussion 622-613
4. R. Damhuis, A. Coonar, and P. Plaisier A case-mix model for monitoring of postoperative mortality after surgery for lung cancer Lung cancer 51 2006 123 129 (Pubitemid 43088632)
5. C. Alexiou, D. Beggs, and P. Onyeaka Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Ann Thorac Surg 76 2003 1023 1028 (Pubitemid 37204699)
6. J.P. Wisnivesky, M. Bonomi, C. Henschke, M. Iannuzzi, and T. McGinn Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer Chest 128 2005 1461 1467 (Pubitemid 41324433)
7. D.J. Raz, J.A. Zell, S.H. Ou, D.R. Gandara, H. Anton-Culver, and D.M. Jablons Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199 (Pubitemid 47068221)
8. G.S. Sibley Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses - a review Cancer 82 1998 433 438 (Pubitemid 28112979)
9. J. Bradley, M.V. Graham, and K. Winter Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328 (Pubitemid 40164423)
10. J.A. Hayman, M.K. Martel, and R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial J Clin Oncol 19 2001 127 136 (Pubitemid 32063489)
11. K.E. Rosenzweig, J.L. Fox, and E. Yorke Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma Cancer 103 2005 2118 2127 (Pubitemid 40605120)
12. J.D. Lawson, A. Sandhu, S. Jiang, and A.J. Mundt Emerging role of stereotactic radiotherapy (SRT) in teh treatment of early stage non-small cell lung cancer Curr Cancer Therapy Rev 5 2009 281 287
13. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839 (Pubitemid 46630909)
14. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Hoyer Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
15. A.W. Ng, S.Y. Tung, and V.Y. Wong Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer - report on clinical outcome and dose to critical organs Radiother Oncol 87 2008 24 28
16. J.D. Bradley, I. El Naqa, R.E. Drzymala, M. Trovo, G. Jones, and M.D. Denning Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant Int J Radiat Oncol Biol Phys 2009
17. A. Chi, Z. Liao, N.P. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
18. Nath S, Sandhu AP, Jenson L, et al. Frameless image-guided stereotactic body radiation therapy for lung tumors with 4DCT or 4DPET/CT. Clin Lung Cancer 2011, in press.
19. W.T. Watkins, R. Li, J. Lewis, J.C. Park, A. Sandhu, and S.B. Jiang Patient specific motion artifacts in 4DCT Med Phys 37 2010 2855 2861
20. W.Y. Song, S. Kamath, and S. Ozawa A dose comparison study between XVI and OBI CBCT systems Med Phys 35 2008 480 486 (Pubitemid 351190867)
21. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
22. R. Timmerman, L. Papiez, and R. McGarry Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955 (Pubitemid 37433596)
23. P. Fritz, H.J. Kraus, and T. Blaschke Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning Lung cancer 60 2008 193 199 (Pubitemid 351609149)
24. M.T. Milano, Y. Chen, A.W. Katz, A. Philip, M.C. Schell, and P. Okunieff Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy Radiother Oncol 91 2009 301 306
25. G.M. Strauss, J.E. Herndon 2nd, and M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups J Clin Oncol 26 2008 5043 5051
26. T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
27. J.Y. Douillard, R. Rosell, and M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727 (Pubitemid 44283661)
28. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
29. K.M. Pisters, W.K. Evans, and C.G. Azzoli Cancer care ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline J Clin Oncol 25 2007 5506 5518 (Pubitemid 350232227)
30. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360 (Pubitemid 38101630)
31. Y. Ohta, M. Oda, and J. Wu Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis J Thorac Cardiovasc Surg 122 2001 900 906
32. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431 (Pubitemid 41628038)
33. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631 (Pubitemid 39318910)
34. P. Baumann, J. Nyman, and M. Hoyer Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367